Government
ACP calls for more research on medical marijuana
NEWS IN BRIEF — Posted March 17, 2008
In an effort to encourage expanded research into the potential therapeutic benefits of medical cannabis, the American College of Physicians in February released new policy asking the federal government to ease some restrictions. "Unfortunately, research expansion has been hindered by a complicated federal approval process, limited availability of research-grade marijuana and the debate over legalization," the policy report states.
The ACP said it supports programs and funding for rigorous scientific evaluation of medical marijuana use and publication of the findings. It also urges that marijuana be reclassified from a Schedule I controlled drug to a Schedule II or Schedule III. The organization supports exemption from federal criminal prosecution, civil liability or professional sanctioning for physicians who recommend or dispense medical marijuana in compliance with state laws.
AMA policy calls for further adequate, well-controlled studies of medical marijuana in patients who have serious conditions for which preclinical, anecdotal or controlled evidence suggests possible efficacy. It recommends that the drug be retained as a Schedule I substance pending the outcome of such studies.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2008/03/17/gvbf0317.htm.












